[{"Assets_0_Q2_USD":604914000.0,"CommonStockSharesOutstanding_0_Q2_shares":29564684.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-136321000.0,"NetIncomeLoss_2_Q2_USD":-156783000.0,"NetIncomeLoss_1_Q2_USD":-75193000.0,"StockholdersEquity_0_Q2_USD":146576000.0,"Ticker":"ICPT","CIK":"1270073","name":"INTERCEPT PHARMACEUTICALS, INC.","OfficialName":"Intercept Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"493490879.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]